SCHEMBL7076663

SCHEMBL7076663

C[N]S(=O)(=O)c1ccc(-c2ccc(OC)cc2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F2 P00734 2/20 0.56
PRSS1 P07477 2/20 0.56
PRSS2 P07478 2/20 0.56
PRSS3 P35030 2/20 0.56
PKM P14618 5/20 0.55
ALDH1A1 P00352 4/20 0.51
KDM4E B2RXH2 2/20 0.51
GAA P10253 2/20 0.50
MEN1 O00255 1/20 0.50
KMT2A Q03164 1/20 0.50
USP2 O75604 1/20 0.47
HSD17B10 Q99714 1/20 0.47
PTGS2 P35354 4/20 0.47
PTGS1 P23219 3/20 0.47
CA1 P00915 2/20 0.47
CA2 P00918 2/20 0.47
MMP2 P08253 2/20 0.47
MMP1 P03956 1/20 0.47
MMP9 P14780 1/20 0.47
MMP8 P22894 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7301521 0.94 PKM (0.61) F2PRSS1PRSS2PRSS3PKM
SCHEMBL793287 0.80 PKM (0.59) PKMALDH1A1KDM4EGAAUSP2
SCHEMBL6920362 0.79 PKM (0.64) F2PRSS1PRSS2PRSS3PKM
SCHEMBL7503391 0.78 PTGS2 (0.71) PKMALDH1A1KDM4EPTGS2PTGS1
SCHEMBL7078459 0.76 ALDH1A1 (0.48) F2PRSS1PRSS2PRSS3PKM
SCHEMBL7238460 0.76 PKM (0.59) PKMALDH1A1KDM4EGAAUSP2
SCHEMBL6849995 0.76 PTGS2 (0.72) PKMALDH1A1PTGS2PTGS1CA1
SCHEMBL2947753 0.76 PKM (0.59) F2PRSS1PRSS2PRSS3PKM
SCHEMBL14456654 0.74 PKM (0.76) PKMALDH1A1KDM4EGAAUSP2
SCHEMBL12883762 0.74 PKM (0.57) PKMALDH1A1KDM4EUSP2HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030144292-A1 Carbocyclic side chain containing, N-substituted metalloprotease inhibitors PROCTER & GAMBLE COMPANY, THE 2003-07-31 US claimed
US-20030162778-A1 Carbocyclic side chain containing metalloprotease inhibitors THE PROCTER AND GAMBLE COMPANY 2003-08-28 US disclosed
US-20030144292-A1 Carbocyclic side chain containing, N-substituted metalloprotease inhibitors PROCTER & GAMBLE COMPANY, THE 2003-07-31 US disclosed
EP-1265887-A2 CARBOCYCLIC SIDE CHAIN CONTAINING METALLOPROTEASE INHIBITORS THE PROCTER & GAMBLE COMPANY (US) 2002-12-18 EP disclosed
EP-1265886-A2 CARBOCYCLIC SIDE CHAIN CONTAINING, N-SUBSTITUTED METALLOPROTEASE INHIBITORS THE PROCTER & GAMBLE COMPANY (US) 2002-12-18 EP disclosed
WO-2001070682-A2 CARBOCYCLIC SIDE CHAIN CONTAINING METALLOPROTEASE INHIBITORS THE PROCTER & GAMBLE COMPANY (US) 2001-09-27 WO disclosed
WO-2001070720-A2 CARBOCYCLIC SIDE CHAIN CONTAINING, N-SUBSTITUTED METALLOPROTEASE INHIBITORS THE PROCTER & GAMBLE COMPANY (US) 2001-09-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030162778-A1 Carbocyclic side chain containing metalloprotease inhibitors MMP2, CMA1, SERPINB1 F2 687/4885PRSS1 32/4885PRSS2 53/4885
US-20030144292-A1 Carbocyclic side chain containing, N-substituted metalloprotease inhibitors MMP2, MMP3, CMA1 F2 780/4885PRSS1 41/4885PRSS2 56/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.